- Q&A: talking clinical trial tech and acquisitions with Medidata
- Oxford VR secures $12.5m investment for VR therapy tech
- New analysis raises concerns over accuracy of skin cancer risk apps
- Bone marrow chip opens research options for Shwachman-Diamond syndrome
- DiviTum validated as early evaluation tech for metastatic breast cancer
Medicare Taiwan Expo 2020
The 2020 MEDICARE TAIWAN (Taiwan International Medical & Healthcare Exhibition) tradeshow creates an international platform that focuses on medical devices, hospital equipment and healthcare solutions in Taiwan.
Endotronix enrols two patients for PROACTIVE-HF pivotal trial
US-based digital health and medical technology company Endotronix has enrolled first two patients in the PROACTIVE-HF pivotal trial, a pre-market investigational device-exempt (IDE) study evaluating the safety and efficacy of the Cordella Sensor.
Q&A: talking clinical trial tech and acquisitions with Medidata
Medidata's clinical trial tech is used in approximately half of all life science research products around the world. Now, the company has been acquired by Dassault Systèmes, in a merger that could be transformative for the medtech and pharma industries. Chloe Kent speaks to three of Medidata’s key players to find out more.
Seegene secures approval in South Korea for Covid-19 assay
Seegene has received approval from the South Korea Ministry of Food and Drug Safety for its novel coronavirus (Covid-19) Real-time PCR assay for emergency use.
HeadaTerm’s TENS therapy provides treatment for acute migraines
WAT Medical has announced that the HeadaTerm TENS device in a clinical study reduced acute migraine pain 11.8% more than any other migraine medications.
Reliable Cervical Cancer Screening
Based on available study data, GynTect® provides a clear indication of malignancy status in patients with abnormal Pap smear: In all previous studies, GynTect® was able to detect all cancer cases of the cervix (Sensitivity = 100%).
Philips to study outcomes of PCI guided by iFR and X-ray images
Royal Philips has announced randomised controlled trial DEFINE GPS to study patient outcomes of percutaneous coronary intervention (PCI) guided by iFR and interventional X-ray images against standard-of-care treatment guided by an angiogram.
Oxford VR secures $12.5m investment for VR therapy tech
UK-based virtual reality (VR) therapy company Oxford VR has announced the completion of a $12.5m Series A funding round led by Optum Ventures and supported by Luminous Ventures.
New analysis raises concerns over accuracy of skin cancer risk apps
An evaluation of the accuracy of smartphone apps that claim to risk-stratify moles and skin lesions has found that they are poorly regulated and often cannot be trusted to produce accurate results.
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.
On 5 April 2017, two new Medical Devices Regulations (MDR) on medical devices were adopted, and they entered into…